BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15902326)

  • 21. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
    Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
    Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiles in HPV-infected head and neck cancer.
    Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
    J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Herbst RS; Bajorin DF; Bleiberg H; Blum D; Hao D; Johnson BE; Ozols RF; Demetri GD; Ganz PA; Kris MG; Levin B; Markman M; Raghavan D; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Vokes EE; Winn RJ; Mayer RJ;
    J Clin Oncol; 2006 Jan; 24(1):190-205. PubMed ID: 16326753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A systemic dynamic modeling for prognosis of the quantity of the cancer patients in various clinical categories and for the assessment of the needs in resources].
    Bukharbaeva LIa; Rakhmatullina IR; Taniukevich MV
    Med Tekh; 2004; (2):30-4. PubMed ID: 15148888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Southwest Oncology Group: progress in cancer research.
    Coltman CA;
    Semin Oncol; 2008 Oct; 35(5):545-52. PubMed ID: 18929152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
    van Agthoven T; Sieuwerts AM; Meijer-van Gelder ME; Look MP; Smid M; Veldscholte J; Sleijfer S; Foekens JA; Dorssers LC
    J Clin Oncol; 2009 Feb; 27(4):542-9. PubMed ID: 19075277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new era in cancer research.
    Varmus H
    Science; 2006 May; 312(5777):1162-5. PubMed ID: 16728627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
    Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH
    Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robert Weinberg.
    Weinberg R
    Nat Biotechnol; 2011 Mar; 29(3):192. PubMed ID: 21390011
    [No Abstract]   [Full Text] [Related]  

  • 37. Quick cancer screen: you can do it for every patient.
    Gray JC; Judkins AF; Patterson JE; White LN
    RN; 1980 Jan; 43(1):42-50. PubMed ID: 6898069
    [No Abstract]   [Full Text] [Related]  

  • 38. [E.N.T. carcinology in the last 25 years].
    Gaillard J; Gignoux B
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1982 Jun; 31(6):397-9. PubMed ID: 6216302
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer report.
    Br Med J; 1970 Dec; 4(5738):760-1. PubMed ID: 5497401
    [No Abstract]   [Full Text] [Related]  

  • 40. CAMEO--Cancer Management and Education Optimization.
    Watson FR; Glass RL
    Mo Med; 1970 Dec; 67(12):875-7. PubMed ID: 5495900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.